Literature DB >> 31875449

[Research progress on interactions between Candida albicans and common oral pathogens].

Ling Deng1, Jing Xue2, Li Jiang3, Ling Zou2, Wei Li1.   

Abstract

Increasing numbers of microbiome studies have enabled the development of a greater understanding of how antagonistic and synergetic microbial interactions influence disease outcomes. Candida albicans is an opportunistic pathogen that is commonly found in human oral microflora. In a healthy oral environment, Candida albicans may potentially but sig-nificantly influence the balance between the oral bacterial ecosystem and the host, leading tooral diseases. The aim of this study is to review the correlation between Candida albicans and oral pathogens and provide a deeper understanding of the nature of oral infec-tious diseases.

Entities:  

Keywords:  Candida albicans; bacteria; interaction

Mesh:

Year:  2019        PMID: 31875449      PMCID: PMC7030748          DOI: 10.7518/hxkq.2019.06.018

Source DB:  PubMed          Journal:  Hua Xi Kou Qiang Yi Xue Za Zhi        ISSN: 1000-1182


  42 in total

1.  Transcriptional landscape of trans-kingdom communication between Candida albicans and Streptococcus gordonii.

Authors:  L C Dutton; K H Paszkiewicz; R J Silverman; P R Splatt; S Shaw; A H Nobbs; R J Lamont; H F Jenkinson; M Ramsdale
Journal:  Mol Oral Microbiol       Date:  2015-07-07       Impact factor: 3.563

2.  Symbiotic relationship between Streptococcus mutans and Candida albicans synergizes virulence of plaque biofilms in vivo.

Authors:  Megan L Falsetta; Marlise I Klein; Punsiri M Colonne; Kathleen Scott-Anne; Stacy Gregoire; Chia-Hua Pai; Mireya Gonzalez-Begne; Gene Watson; Damian J Krysan; William H Bowen; Hyun Koo
Journal:  Infect Immun       Date:  2014-02-24       Impact factor: 3.441

3.  Antigen I/II mediates interactions between Streptococcus mutans and Candida albicans.

Authors:  C Yang; J Scoffield; R Wu; C Deivanayagam; J Zou; H Wu
Journal:  Mol Oral Microbiol       Date:  2018-04-26       Impact factor: 3.563

4.  Probiotic lactobacilli inhibit early stages of Candida albicans biofilm development by reducing their growth, cell adhesion, and filamentation.

Authors:  Victor Haruo Matsubara; Yi Wang; H M H N Bandara; Marcia Pinto Alves Mayer; Lakshman P Samaranayake
Journal:  Appl Microbiol Biotechnol       Date:  2016-04-18       Impact factor: 4.813

5.  The impact of oral contraceptives on women's periodontal health and the subgingival occurrence of aggressive periodontopathogens and Candida species.

Authors:  María Isabel Brusca; Alcira Rosa; Olatz Albaina; María D Moragues; Fernando Verdugo; José Pontón
Journal:  J Periodontol       Date:  2010-07       Impact factor: 6.993

6.  Enterococcus faecalis bacteriocin EntV inhibits hyphal morphogenesis, biofilm formation, and virulence of Candida albicans.

Authors:  Carrie E Graham; Melissa R Cruz; Danielle A Garsin; Michael C Lorenz
Journal:  Proc Natl Acad Sci U S A       Date:  2017-04-10       Impact factor: 11.205

7.  Inhibitory effects of Lactobacillus fermentum on microbial growth and biofilm formation.

Authors:  Oxana V Rybalchenko; Viktor M Bondarenko; Olga G Orlova; Alexander G Markov; S Amasheh
Journal:  Arch Microbiol       Date:  2015-08-13       Impact factor: 2.552

8.  Soluble factors from biofilm of Candida albicans and Staphylococcus aureus promote cell death and inflammatory response.

Authors:  Kassia de Carvalho Dias; Paula Aboud Barbugli; Fernanda de Patto; Virginia Barreto Lordello; Letícia de Aquino Penteado; Alexandra Ivo Medeiros; Carlos Eduardo Vergani
Journal:  BMC Microbiol       Date:  2017-06-30       Impact factor: 3.605

9.  Effects of Streptococcus sanguinis Bacteriocin on Deformation, Adhesion Ability, and Young's Modulus of Candida albicans.

Authors:  Shengli Ma; Wenyu Ge; Yifan Yan; Xu Huang; Li Ma; Chunmei Li; Shuyang Yu; Chunxiao Chen
Journal:  Biomed Res Int       Date:  2017-05-22       Impact factor: 3.411

Review 10.  Streptococcus mutans, Candida albicans, and the human mouth: a sticky situation.

Authors:  Khalid H Metwalli; Shariq A Khan; Bastiaan P Krom; Mary Ann Jabra-Rizk
Journal:  PLoS Pathog       Date:  2013-10-17       Impact factor: 6.823

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.